{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-24-000084","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2024-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.723971+00:00","generated_at":"2026-05-31T19:10:19.375880+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"GRI Bio increases ATM offering capacity by up to $1.04M, excluding prior $0.96M sales","bullets":["Increased maximum aggregate sales price of shares under ATM agreement with H.C. Wainwright to $1,038,886, excluding $961,272 already sold.","ATM agreement originally dated May 20, 2024; prospectus supplement filed July 19, 2024.","Shares to be issued are common stock, par value $0.0001 per share; legal opinion from Mintz, Levin filed as exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-24-000084","json":"https://secwatch.observer/filing/0001824293-24-000084.json","markdown":"https://secwatch.observer/filing/0001824293-24-000084.md","text":"https://secwatch.observer/filing/0001824293-24-000084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000084/0001824293-24-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000084/val-20240719.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T19:10:19.375880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}